Prostate News Archive
14-Jul-2011
For Some Prostate Cancer Patients, Combo Treatment Improves Survival
WEDNESDAY, July 13 (HealthDay News) -- For men who have prostate cancer that's considered "intermediate risk," radiation plus four months of hormone therapy appears to improve survival, a new study finds. Combination Therapy May Treat Prostate Cancer
For some men with early-stage prostate cancer, adding short-term hormone treatment to radiation therapy improves their chances of survival, according to a new study. Hormone Drugs May Boost Life Expectancy for Prostate Cancer Patients
Some prostate cancer patients may improve their long-term survival chances by receiving hormone suppression drugs such as Abbott Laboratories (ABT) ? Lupron and AstraZeneca Plc (AZN) ?s Zoladex with radiation therapy, a study showed.
Back to Prostate News Archive
